The short version of 脂肪营养不良 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-16 and is reviewed periodically as new material appears.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Amino acid length | 44 residues | Matches the native peptide backbone |
| Molecular weight | Approximately 5135 Da | Calculated from the peptide sequence |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
| Primary studied use | Visceral fat reduction | Investigated in HIV-associated lipodystrophy |
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
=== Calibration materials === Calibration materials are compounds whose isotopic composition is known extremely well relative to the primary reference materials or which define the isotopic composition of the primary reference materials but are not the isotopic ratios to which data are reported in the scientific literature. For example, the calibration material IAEA-S-1 defines the isotopic scale for sulfur but measurements are reported relative to VCDT, not relative to IAEA-S-1. The calibration material serves the function of the primary reference material when the primary reference is exhausted, unavailable, or never existed in physical form.
The trial followed participants for 29 days and included 1,033 participants with moderate or severe COVID-19; 515 participants received baricitinib plus remdesivir, and 518 participants received placebo plus remdesivir. Recovery was defined as either being discharged from the hospital or being hospitalized but not requiring supplemental oxygen and no longer requiring ongoing medical care. The median time to recovery from COVID-19 was seven days for baricitinib plus remdesivir and eight days for placebo plus remdesivir. The odds of a patient's condition progressing to death or being ventilated at day 29 was 31% lower in the baricitinib plus remdesivir group versus the placebo plus remdesivir group. The odds of clinical improvement at day 15 was 30% higher in the baricitinib plus remdesivir group versus the placebo plus remdesivir group. For all of these endpoints, the effects were statistically significant. The EUA was issued to Eli Lilly and Company. In November 2020, the World Health Organization (WHO) updated its guideline on therapeutics for COVID-19 to include a conditional recommendation against the use of remdesivir, triggered by results from the WHO Solidarity trial. In November 2020, the FDA issued an emergency use authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized people aged two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
== Research and academic contributions == Eke's research focuses on optimizing the safe and effective use of medications in pregnancy and lactation. His work spans pharmacokinetics, pharmacodynamics, pharmacoepidemiology, pharmacogenomics, and pharmacometrics. He has led clinical and translational research on drug safety, dosing, and interactions in pregnant women, particularly in relation to preterm birth, HIV, hepatitis C, tuberculosis, sickle cell disease, hypertensive disorders of pregnancy, and substance use disorders. His studies integrate approaches such as longitudinal cohort designs, intensive and sparse pharmacokinetic sampling, population-based modeling, physiologically based pharmacokinetic modelling, and real-world data analysis. He has pioneered the use of high-dimensional omics such as proteomics and metabolomics in investigating the pathophysiology of complex pregnancy-related conditions. This work contributes to the development of personalized pharmacotherapy strategies and regulatory guidance for medication use during pregnancy. Eke has received multiple research grants from the NIH, including a Women's Reproductive Health Research (WRHR) Career Development award, a K23 Career Development award, and a National Institutes of Health Director's Pioneer Award (DP1), which supports innovative and high-impact research.
Sources: en.wikipedia.org
Pakistan's landscapes vary from coastal plains to glaciated mountains, offering deserts, forests, hills, and plateaus. Pakistan is divided into three major geographic areas: the northern highlands, the Indus River plain, and the Balochistan Plateau. The northern highlands feature the Karakoram, Hindu Kush, and Pamir mountain ranges, hosting some of the world's highest peaks, including five of the fourteen eight-thousanders (mountain peaks over 8,000 metres or 26,250 feet), notably K2 (8,611 m or 28,251 ft) and Nanga Parbat (8,126 m or 26,660 ft). The Balochistan Plateau lies in the west and the Thar Desert in the east. The 1,609 km (1,000 mi) Indus River and its tributaries traverse the nation from Kashmir to the Arabian Sea, sustaining alluvial plains along the Punjab and Sindh regions. The climate varies from tropical to temperate, with arid conditions in the coastal south. There is a monsoon season with frequent flooding due to heavy rainfall, and a dry season with significantly less rainfall or none at all. Pakistan experiences four distinct seasons: a cool, dry winter from December through February; a hot, dry spring from March through May; the summer rainy season, or southwest monsoon period, from June through September; and the retreating monsoon period of October and November. Rainfall varies greatly from year to year, with patterns of alternate flooding and drought common.
Abrocitinib, sold under the brand name Cibinqo, is a medication used for the treatment of atopic dermatitis (eczema). It is a Janus kinase inhibitor and it was developed by Pfizer. It is taken by mouth. The most common side effects include nausea (feeling sick), headache, acne, herpes simplex (viral infection of the mouth or the genitals), increased levels of creatine phosphokinase in the blood (an enzyme released into the blood when muscle is damaged), vomiting, dizziness and pain in the upper belly. Abrocitinib was approved for medical use in the European Union in December 2021, and in the United States in January 2022.
The letter was seized on by the Committee, who immediately released £4,000 to begin development. They petitioned Hugh Dowding, the Air Member for Supply and Research, to ask the Treasury for another £10,000. Dowding was extremely impressed with the concept, but demanded a practical demonstration before further funding was released. Wilkins suggested using the new 10 kW, 49.8 m BBC Borough Hill shortwave station in Daventry, Northamptonshire as a suitable ad hoc transmitter. The receiver and an oscilloscope were placed in a delivery van the RRS used for measuring radio reception around the countryside. On 26 February 1935, they parked the van in a field near Upper Stowe and connected it to wire antennas stretched across the field on top of wooden poles. A Handley Page Heyford made four passes over the area, producing clearly notable effects on the CRT display on three of the passes. A memorial stone was placed at the site of the test. Observing the test were Watt, Wilkins, and several other members of the RRS team, along with Rowe representing the Tizard Committee. Watt was so impressed he later claimed to have exclaimed: "Britain has become an island again!" Rowe and Dowding were equally impressed. It was at this point that Watt's previous agitation over development became important; NPL management remained uninterested in practical development of the concept, and was happy to allow the Air Ministry to take over the team.
Sources: en.wikipedia.org
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.
The synthetic peptide incorporates modifications that slow enzymatic breakdown in circulation. Native growth hormone-releasing hormone is short-lived, whereas the analog is designed for greater stability. The core amino acid backbone is largely retained.
The main studied application is reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. Research has measured fat changes through imaging. Findings concern fat distribution rather than overall body weight.
特沙莫瑞林是国际非专利名称，指一种经过 N 端修饰的生长激素释放激素类似物。它被归类为合成肽，序列与 GHRH(1-44) 密切相关。该名称不指代任何特定品牌或剂型。